SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Renin-Angiotensin-Aldosterone System
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tone, A.
Right arrow Articles by Makino, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tone, A.
Right arrow Articles by Makino, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Changes of gene expression profiles in macrophages stimulated by angiotensin II — Angiotensin II induces MCP-2 through AT1-receptor

Atsuhito Tone

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Kenichi Shikata

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, shikata{at}md.okayama-u.ac.jp

Daisuke Ogawa

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Sakiko Sasaki

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Ryo Nagase

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Motofumi Sasaki

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Kosuke Yozai

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Hitomi Kataoka Usui

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Shinichi Okada

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Jun Wada

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Yasushi Shikata

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Hirofumi Makino

Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

Introduction. Macrophages play critical roles in the development of atherosclerosis and diabetic nephropathy as well as many inflammatory diseases. Angiotensin II type 1 receptor antagonists (AIIA) are beneficial for the prevention of atherosclerosis and diabetic nephropathy suggesting that angiotensin II (Ang II) promotes the development of these diseases. It has recently been reported that Ang II exerts proinflammatory actions in vivo and in vitro. This study was aimed to clarify the direct effects of Ang II on monocytes/macrophages.

Materials and methods. PMA-treated THP-1 cells, a human monocytic leukaemia cell line, were treated with Ang II (10-6 mol/L) for 24 hours with or without AIIA (CV11974). We evaluated gene expression profiles of these cells using DNA microarray system and quantified them by real-time RT-PCR.

Results. DNA microarray revealed that in total 19 genes, including monocyte chemoattractant protein (MCP)-2, were up-regulated by Ang II and down-regulated by AIIA. Real-tim D e RT-PCR showed that up-regulation of MCP-2 with Ang II is blocked by the AIIA (CV11974) but not by an AT2-receptor antagonist.

Conclusions. These results suggest that Ang II directly stimulates MCP-2 expression through AT1-receptors in activated macrophages.Ang II may contribute to the persistence or amplification of microinflammation in vessel walls, heart and kidney.Vasculoprotective or renoprotective effects of AIIA might partly depend on direct antiinflammatory effects on macrophages.

Key Words: angiotensin II • MCP-2 • macrophage • chemokine • candesartan • renin-angiotensin system • THP-1 • DNA array

References

  • Hernandez-Presa M., Bustos C., Ortego M. et al. Angiotensin-converting enzyme inhibition prevents arterial nuclear factorkappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997;95:1532-41.[Abstract/Free Full Text]
  • Hirata K., Shikata K., Matsuda M. et al. Increased expression of selectins in kidneys of patients with diabetic nephropathy, Diabetologia 1998;41:185-92.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sugimoto H., Shikata K., Hirata K. et al. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 1997;46:2075-81.[Abstract]
  • Okada S., Shikata K., Matsuda M. et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 2003;52:2586-93.[Abstract/Free Full Text]
  • Usui H., Shikata K., Matsuda M. et al. MG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transplant 2003;18:265-72.[Abstract/Free Full Text]
  • Dzau VJ Vascular renin-angiotensin system and vascular protection. J Cardiovasc Pharmacol 1993;22(suppl 5):S1-S9.
  • Diet F., Pratt RE, Berry GJ, Momose, Gibbons GH, Dzau VJ Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996;94:2756-67.[Abstract/Free Full Text]
  • Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM Angiotensin II induces monocyte chemoattractant protein P -1 gene expression in rat vascular smooth muscle cells. Circ Res 1998;83:952-9.[Abstract/Free Full Text]
  • Potter DD, Sobey CG, Tompkins PK, Rossen JD, Heistad DD Evidence that macrophages in atherosclerotic lesions contain angiotensin II. Circulation 1998;98:800-07.[Abstract/Free Full Text]
  • Iwai N., Inagami T., Ohmichi N., Kinoshita M. Renin is expressed in rat macrophage/monocyte cells. Hypertension 1996;27:399-403.[Abstract/Free Full Text]
  • Okamura A., Rakugi H., Ohishi M. et al. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. J Hypertens 1999;17:537-45.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Yanagitani Y., Rakugi H., Okamura A. et al. Angiotensin II type 1 receptor-mediated peroxide production in human macrophages. Hypertension 1999;33:335-9.[Abstract/Free Full Text]
  • Kato S., Luyckx VA, Ots M. et al. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kidney Int 1999;56:1037-48.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mezzano S., Droguett A., Burgos ME et al. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int Suppl 2003;86:S64-S70.[Medline] [Order article via Infotrieve]
  • Ramakrishnan R., Dorris D., Lublinsky A. et al. An assessment of Motorola CodeLink microarray performance for gene expression profiling applications. Nucleic Acids Res 2002;30:e30.[Abstract/Free Full Text]
  • Amann B., Tinzmann R., Angelkort B. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. Diabetes Care 2003;26:2421-5.[Abstract/Free Full Text]
  • Goodfriend TL, Elliott ME, Catt KJ Angiotensin receptors and their antagonists. N Engl J Med 1996;334:1649-54.[Free Full Text]
  • Ardaillou R. Angiotensin II receptors. J Am Soc Nephrol 1999;10(suppl 11):S30-39.[Web of Science][Medline] [Order article via Infotrieve]
  • Carey RM, Wang ZQ, Siragy HM Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function. Hypertension 2000;35:155-63.[Abstract/Free Full Text]
  • Stoll M., Steckelings UM, Paul M., Bottari SP, Metzger R., Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995:95:651-7.[Web of Science][Medline] [Order article via Infotrieve]
  • Kuizinga MC, Smits JF, Arends JW, Daemen M. AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J Mol Cell Cardiol 1998;30:425-34.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Maric C., Aldred GP, Harris PJ, Alcorn D. Angiotensin II inhibits growth of cultured embryonic renomedullary interstitial cells through the AT2 receptor. Kidney Int 1998;53:92-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Yamada T., Horiuchi M., Dzau VJ Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA 1996;93:156-60.[Abstract/Free Full Text]
  • Hines J., Fluharty SJ, Yee DK Chimeric AT1/AT2 receptors reveal functional similarities despite key amino acid dissimilarities in the domains mediating agonist-dependent activation. Biochemistry 2001;40:11251-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Esteban V., Lorenzo O., Ruperez M. et al. Ruiz-Ortega, Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol 2004;15:1514-29.[Abstract/Free Full Text]
  • Decock B., Conings R., Lenaerts JP, Billiau A., Van Damme J. Identification of the monocyte chemotactic protein from human osteosarcoma cells and monocytes: detection of a novel N-terminally processed form. Biochem Biophys Res Commun 1990;167:904-09.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gong X., Gong W., Kuhns DB et al. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptor. J Biol Chem 1997;272:11682-5.[Abstract/Free Full Text]
  • Ruffing N., Sullivan N., Sharmeen L., Sodroski J., Wu L. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells. Cell Immunol 1998;189:160-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Taub DD, Proost P., Murphy WJ et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995;95:1370-6.[Web of Science][Medline] [Order article via Infotrieve]
  • Uguccioni M., D'Apuzzo M., Loetscher M., Dewald B., M. Baggiolini. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J Immunol 1995;25:64-8.[Web of Science][Medline] [Order article via Infotrieve]
  • Weber M., Uguccioni M., Ochensberger B., Baggiolini M., Clark-Lewis I., Dahinden CA Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol 1995;154:4166-72.[Abstract]
  • Noso N., Proost P., Van Damme J., Schroder JM Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitise the chemotactic responses towards RANTES. Biochem Biophys Res Commun 1994;200:1470-6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 8, No. 1, 45-50 (2007)
DOI: 10.3317/jraas.2007.007


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
E. I. Ager, J. Neo, and C. Christophi
The renin-angiotensin system and malignancy
Carcinogenesis, September 1, 2008; 29(9): 1675 - 1684.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Tone, A.
Right arrow Articles by Makino, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tone, A.
Right arrow Articles by Makino, H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement